RCEL: SEC Form 4 filed by Avita Medical Inc.

Historical context for RCEL

Across the 14 sessions after earlier RCEL headlines, the stock closed higher 7 times and lower 6 times, with a median move of 2.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

Earlier insider filings at RCEL

• Feb 23, 2026CFO O'Toole David D bought $12,450 worth of shares (3,000 units at $4.15), increasing direct ownership by 2% to 140,127 units (SEC Form 4)
• Feb 19, 2026CFO O'Toole David D was granted 105,470 shares, increasing direct ownership by 333% to 137,127 units (SEC Form 4)
• Feb 19, 2026Chief Legal Officer Kelsey Nicole was granted 98,390 shares (SEC Form 4)
• Aug 29, 2025Director Mcnamara Robert bought $45,000 worth of shares (10,000 units at $4.50), increasing direct ownership by 13% to 86,771 units (SEC Form 4)
• Aug 26, 2025CFO O'Toole David D bought $9,040 worth of shares (2,000 units at $4.52), increasing direct ownership by 7% to 31,657 units (SEC Form 4)